Clinical Trial Update: Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating the combination of ursodeoxycholic acid (UDCA) and all-trans retinoic acid (ATRA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Yale University | Conditions: Cholangitis, Sclerosing | Phase 1 | Status: COMPLETED